Fig. 2From: Optimal duration of Vitamin K antagonists anticoagulant therapy after venous thromboembolism: a systematic review and network meta-analysis of randomized controlled trialsa-b Sensitivity analysis representing the risk for major bleeding after excluding single trial between longer and shorter duration for (a) the entire period and (b) during anticoagulationBack to article page